Emerging Biotech
Viva Biotech's Portfolio Company, Riparian Pharmaceuticals, Partners with Pfizer for Novel Cardiovascular Programs
In exchange for exclusive rights to a Riparian preclinical program, Pfizer will make upfront and milestone payments, as well as pay royalties on sales of r...
July 21, 2023 | News
Biotheus Partners with BioNTech in Global Research Collaboration & License Deal
Under the terms of the agreement, Biotheus will grant BioNTech worldwide, exclusive options to a preclinical-stage bispecific antibody and a clinical-stage...
July 20, 2023 | News
BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program
Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS Underpinned by proprietary IV-formulated, Brain-targeting Ribonucleic Ac...
July 18, 2023 | News
Chinese Scientists Extract 'Red Marrow Peptide' from Young Yaks, Promising Breakthrough for Cardiovascular Health
As an important hematopoietic and metabolic immune organ of human body, red blood marrow is known as the systematic "soldier factory". Red blood marrow is ...
July 17, 2023 | News
ENPICOM secures extended financing to continue driving breakthroughs in therapeutic discovery
ENPICOM, an innovative bioinformatics software engineering company, has successfully secured further financial backing from its current investors BOP Capit...
July 07, 2023 | News
GenScript Doubles cGMP sgRNA and Non-Viral DNA Payload Manufacturing Capacity
GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its cGMP manufacturing capacity...
July 07, 2023 | News
Sirnaomics Forms Strategic Partnership with EDIRNA Inc. in RNA-Editing Therapeutics
EDIRNA is a start-up biotech company focusing on RNA-Editing therapeutics and taking advantage of the Group's proprietary technology platforms for novel RN...
July 06, 2023 | News
TiumBio and Hansoh Pharma Secure NMPA Approval for 'HS-10518/TU2670' Clinical Trial in China
TiumBio will complete the last patient dosing in a Phase 2a clinical trial of TU2670 in endometriosis in Europe by the end of the year TiumBio C...
July 06, 2023 | News
Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
July 03, 2023 | News
Lifera and CENTOGENE Form Strategic Saudi Joint Venture for Enhanced Multiomic Testing Access
Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly own...
July 03, 2023 | News
Lion TCR Raises $40M in Series B2 Funding, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy
The funds raised will be used primarily to support Lion TCR's clinical trials on hepatitis B virus (HBV)-specific TCR T cell therapy, while also facilitati...
June 28, 2023 | News
Psylo Partners with Daiichi Sankyo for Non-Hallucinogenic Psychiatric Therapies
Biotech start-up, Psylo, announced that it has entered into a Sponsored Research Agreement with global Japanese pharmaceutical company, Daiichi ...
June 23, 2023 | News
"Jumar Bioincubator" calls for next-gen biotechs, appoints new GM
The "Jumar Bioincubator" will be supported by cash and in-kind contributions of approximately $45 million over ten years from its founding partne...
June 22, 2023 | News
AstraZeneca Collaborates with Cholesgen for Hypercholesterolemia Drug Discovery and Licensing Agreement
This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...
June 19, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
